Application Segmentation: The Full Body UV Phototherapy Device market is primarily categorized by Application into Psoriasis, Vitiligo, Atopic Dermatitis, and Others (e.g., eczema, autoimmune skin disorders). Psoriasis dominates the market, accounting for over 40% of demand, due to its chronic nature and the efficacy of UVB therapy in reducing plaque formation. Vitiligo represents a significant segment, driven by the need for controlled repigmentation through narrowband UVB treatments. Atopic Dermatitis is a rapidly growing application, fueled by rising prevalence of allergic conditions and the therapeutic potential of phototherapy in modulating immune responses. The Others category includes emerging indications, contributing to market diversification. Full Body UV Phototherapy Device segmentation by application underscores the interplay between disease prevalence, treatment protocols, and technological adoption, shaping the overall market dynamics.